Hypercholesterolemia (also known as high cholesterol) occurs when abnormally high levels of certain types of cholesterol are in the blood (>5.2 mmol/L). This increase of cholesterol can cause plaque buildup in the artery walls, inevitably causing damage to organs and tissues as blood flow is restricted. Borderline hypercholesterolemia is defined when levels are between 200-239 mg/dL. Hypercholesterolemia is significantly correlated with increased incidence and risk of atherosclerosis, heart attack, and stroke. Risk for developing hypercholesterolemia is increased with smoking, diabetes, high blood pressure, obesity, and poor exercise in combination with a poor diet. Nonfamilial hypercholesterolemia is the most common form of hypercholesterolemia as it is present in individuals with a susceptible genotype that is aggravated by excessive amounts of saturated fats and cholesterol. Familial hypercholesterolemia is a genetic disorder that is inherited, making prevalence within a family approximately 50%. Treatments focus on reducing the risk of cardiovascular disease by decreasing blood cholesterol levels. Medications may be diagnosed to help with this process.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Borderline Hypercholesterolaemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 381 products for the study of Borderline Hypercholesterolaemia that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.